Literature DB >> 32326852

B Cell Activation and Response Regulation During Viral Infections.

Jonathan H Lam1,2, Fauna L Smith2,3, Nicole Baumgarth1,2,3,4.   

Abstract

Acute viral infections are characterized by rapid increases in viral load, leading to cellular damage and the resulting induction of complex innate and adaptive antiviral immune responses that cause local and systemic inflammation. Successful antiviral immunity requires the activation of many immune cells, including T cells, natural killer cells, and macrophages. B cells play a unique part through their production of antibodies that can both neutralize and clear viral particles before virus entry into a cell. Protective antibodies are produced even before the first exposure of a pathogen, through the regulated secretion of so-called natural antibodies that are generated even in the complete absence of prior microbial exposure. An early wave of rapidly secreted antibodies from extrafollicular (EF) responses draws on the preexisting naive or memory repertoire of B cells to induce a strong protective response that in kinetics tightly follows the clearance of acute infections, such as with influenza virus. Finally, the generation of germinal centers (GCs) provides long-term protection through production of long-lived plasma cells and memory B cells, which shape and broaden the B cell repertoire for more effective responses following repeat exposures. In this study, we review B cell responses to acute viral infections, primarily influenza virus, from the earliest nonspecific B-1 cell to early, antigen-specific EF responses and finally to GC responses. Throughout, we address known factors that lead to distinct B cell response outcomes and discuss how their functions effect viral clearance, highlighting the critical contributions of each response type to the induction of highly protective antiviral humoral immunity.

Entities:  

Keywords:  B cell responses; B cells; B-1 cells; extrafollicular responses; germinal center responses; immune regulation

Mesh:

Substances:

Year:  2020        PMID: 32326852      PMCID: PMC7247032          DOI: 10.1089/vim.2019.0207

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  140 in total

1.  Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway.

Authors:  Varsha Kumar; Elke Scandella; Renzo Danuser; Lucas Onder; Maximilian Nitschké; Yoshinori Fukui; Cornelia Halin; Burkhard Ludewig; Jens V Stein
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

Review 2.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

3.  Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.

Authors:  Esra Ozcan; Ingrid Rauter; Lilit Garibyan; Stacey R Dillon; Raif S Geha
Journal:  J Allergy Clin Immunol       Date:  2011-07-07       Impact factor: 10.793

4.  Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection.

Authors:  R Littaua; I Kurane; F A Ennis
Journal:  J Immunol       Date:  1990-04-15       Impact factor: 5.422

5.  High affinity germinal center B cells are actively selected into the plasma cell compartment.

Authors:  Tri Giang Phan; Didrik Paus; Tyani D Chan; Marian L Turner; Stephen L Nutt; Antony Basten; Robert Brink
Journal:  J Exp Med       Date:  2006-10-09       Impact factor: 14.307

6.  Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation.

Authors:  Didrik Paus; Tri Giang Phan; Tyani D Chan; Sandra Gardam; Antony Basten; Robert Brink
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

7.  Memory B Cells that Cross-React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires.

Authors:  Kevin R McCarthy; Akiko Watanabe; Masayuki Kuraoka; Khoi T Do; Charles E McGee; Gregory D Sempowski; Thomas B Kepler; Aaron G Schmidt; Garnett Kelsoe; Stephen C Harrison
Journal:  Immunity       Date:  2018-01-16       Impact factor: 43.474

8.  Positive selection of anti-thy-1 autoreactive B-1 cells and natural serum autoantibody production independent from bone marrow B cell development.

Authors:  Kyoko Hayakawa; Masanao Asano; Susan A Shinton; Ming Gui; Li-Jun Wen; Joni Dashoff; Richard R Hardy
Journal:  J Exp Med       Date:  2003-01-06       Impact factor: 14.307

9.  Signaling by lymphocyte function-associated antigen 1 (LFA-1) in B cells: enhanced antigen presentation after stimulation through LFA-1.

Authors:  V T Moy; A A Brian
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

10.  Plasma cell output from germinal centers is regulated by signals from Tfh and stromal cells.

Authors:  Yang Zhang; Laura Tech; Laura A George; Andreas Acs; Russell E Durrett; Henry Hess; Lucy S K Walker; David M Tarlinton; Anne L Fletcher; Anja Erika Hauser; Kai-Michael Toellner
Journal:  J Exp Med       Date:  2018-03-16       Impact factor: 14.307

View more
  13 in total

Review 1.  The humoral response and antibodies against SARS-CoV-2 infection.

Authors:  Hai Qi; Linqi Zhang; Bo Liu; Xinquan Wang
Journal:  Nat Immunol       Date:  2022-06-27       Impact factor: 31.250

2.  Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19.

Authors:  Maggie L Bartlett; San Suwanmanee; Nadine Peart Akindele; Shristi Ghimire; Andy K P Chan; Chenxu Guo; Stephen J Gould; Andrea L Cox; Diane E Griffin
Journal:  Viral Immunol       Date:  2022-03-14       Impact factor: 2.175

3.  Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.

Authors:  Matthew C Woodruff; Richard P Ramonell; Doan C Nguyen; Kevin S Cashman; Ankur Singh Saini; Natalie S Haddad; Ariel M Ley; Shuya Kyu; J Christina Howell; Tugba Ozturk; Saeyun Lee; Naveenchandra Suryadevara; James Brett Case; Regina Bugrovsky; Weirong Chen; Jacob Estrada; Andrea Morrison-Porter; Andrew Derrico; Fabliha A Anam; Monika Sharma; Henry M Wu; Sang N Le; Scott A Jenks; Christopher M Tipton; Bashar Staitieh; John L Daiss; Eliver Ghosn; Michael S Diamond; Robert H Carnahan; James E Crowe; William T Hu; F Eun-Hyung Lee; Ignacio Sanz
Journal:  Nat Immunol       Date:  2020-10-07       Impact factor: 25.606

Review 4.  Propolis antiviral and immunomodulatory activity: a review and perspectives for COVID-19 treatment.

Authors:  Nicolas Ripari; Arthur Alves Sartori; Mariana da Silva Honorio; Fernanda Lopes Conte; Karen Ingrid Tasca; Karina Basso Santiago; José Maurício Sforcin
Journal:  J Pharm Pharmacol       Date:  2021-03-06       Impact factor: 3.765

Review 5.  Human antiviral B cell responses: Emerging lessons from hepatitis B and COVID-19.

Authors:  Alice R Burton; Mala K Maini
Journal:  Immunol Rev       Date:  2021-02-08       Impact factor: 10.983

6.  Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination.

Authors:  Katharina Röltgen; Sandra C A Nielsen; Oscar Silva; Sheren F Younes; Maxim Zaslavsky; Cristina Costales; Fan Yang; Oliver F Wirz; Daniel Solis; Ramona A Hoh; Aihui Wang; Prabhu S Arunachalam; Deana Colburg; Shuchun Zhao; Emily Haraguchi; Alexandra S Lee; Mihir M Shah; Monali Manohar; Iris Chang; Fei Gao; Vamsee Mallajosyula; Chunfeng Li; James Liu; Massa J Shoura; Sayantani B Sindher; Ella Parsons; Naranjargal J Dashdorj; Naranbaatar D Dashdorj; Robert Monroe; Geidy E Serrano; Thomas G Beach; R Sharon Chinthrajah; Gregory W Charville; James L Wilbur; Jacob N Wohlstadter; Mark M Davis; Bali Pulendran; Megan L Troxell; George B Sigal; Yasodha Natkunam; Benjamin A Pinsky; Kari C Nadeau; Scott D Boyd
Journal:  Cell       Date:  2022-01-25       Impact factor: 66.850

Review 7.  Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?

Authors:  Athanasios Sachinidis; Alexandros Garyfallos
Journal:  Mediterr J Rheumatol       Date:  2021-09-30

8.  PET imaging of TSPO expression in immune cells can assess organ-level pathophysiology in high-consequence viral infections.

Authors:  Swati Shah; Sanhita Sinharay; Reema Patel; Jeffrey Solomon; Ji Hyun Lee; William Schreiber-Stainthorp; Falguni Basuli; Xiang Zhang; Katie R Hagen; Rebecca Reeder; Paul Wakim; Louis M Huzella; Dragan Maric; Reed F Johnson; Dima A Hammoud
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

9.  The Role of T Cells and Macrophages in Asthma Pathogenesis: A New Perspective on Mutual Crosstalk.

Authors:  Xueyi Zhu; Jie Cui; Jingjing Qin; Wuniqiemu Tulake; Fangzhou Teng; Weifeng Tang; Ying Wei; Jingcheng Dong
Journal:  Mediators Inflamm       Date:  2020-08-19       Impact factor: 4.711

10.  Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients.

Authors:  Xavier Charmetant; Maxime Espi; Ilies Benotmane; Véronique Barateau; Francoise Heibel; Fanny Buron; Gabriela Gautier-Vargas; Marion Delafosse; Peggy Perrin; Alice Koenig; Noëlle Cognard; Charlène Levi; Floriane Gallais; Louis Manière; Paola Rossolillo; Eric Soulier; Florian Pierre; Anne Ovize; Emmanuel Morelon; Thierry Defrance; Samira Fafi-Kremer; Sophie Caillard; Olivier Thaunat
Journal:  Sci Transl Med       Date:  2022-03-16       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.